IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
IgA Nephropathy
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreFrom Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss… Read MoreIgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreIgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreDietary Considerations in IgAN
Learn about kidney-friendly dietary tips for managing IgA Nephropathy to support your overall well-being. Read MoreIgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreIgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreUnderstanding the Benefits & Risks of Corticosteroid Use in Patients with IgA Nephropathy (IgAN) (Podcast)
Corticosteroids are one of the most widely used and effective treatment options for many inflammatory and autoimmune diseases. However, long-term use can be associated with adverse events. Read MoreUnderstanding the Benefits & Risks of Corticosteroid Use in Patients with IgA Nephropathy (IgAN) (Infographic Video)
Corticosteroids may be considered, with caution, for patients with IgAN at high risk of progression, according to the 2021 KDIGO guidelines. Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
